GlassScriptPhysician profile
Mary Barr
NPI 1245660554
$795.63
in general payments reported to CMS, 2019-2025
18 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.75 · 2022: $151 · 2023: $382 · 2024: $69.23 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $171.99 | 2021-2023 | Enbrel |
| Asensus Surgical, INC. | $119.71 | 2022-2023 | Senhance |
| Medtronic, INC. | $67.14 | 2023 | Appose Ulc |
| Exact Sciences Corporation | $60.67 | 2023-2024 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $60.09 | 2022-2025 | Tremfya |
| Glaxosmithkline, LLC. | $42.76 | 2022-2023 | Shingrix, Bexsero |
| Sanofi-Aventis U.S. LLC | $38.23 | 2025 | |
| Abbvie INC. | $32.32 | 2023 | |
| Alexion Pharmaceuticals, INC. | $29.76 | 2022 | |
| Depuy Synthes Sales INC. | $25.78 | 2021 | |
| Incyte Corporation | $24.78 | 2025 | Jakafi |
| Boston Scientific Corporation | $22.19 | 2023 | Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $19.86 | 2024 | Lagevrio |
| Novo Nordisk INC | $19.29 | 2025 | Wegovy |
| Taiho Oncology, INC. | $17.89 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.18 | 2024 | Mounjaro |
| Sun Pharmaceutical Industries INC. | $14.14 | 2021 | |
| Octapharma USA, INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.